Cancer firm in $120m order blow after Chinese shun deal

The AIM-listed company behind a revolutionary cancer treatment suffered a major blow today after its Chinese customer pulled the plug on orders worth around $120 million (£96 million). Advanced Oncotherapy, which is developing a proton-beam therapy centre at Harley Street, said Sinophi Healthcare — its only overseas commercial customer — had terminated two orders announced in 2015 that were supposed to be installed at hospitals in China.
Evening Standard